Home » Resources » T/NK Cell Mediated Cytotoxicity Analysis by CFSE, Hoechest 33342 and PI

T/NK Cell Mediated Cytotoxicity Analysis by CFSE, Hoechest 33342 and PI

Experimental Protocol

 

 

 

The cytotoxicity % is calculated by the equation below.
Cytotoxicity % = (Live counts of control – Live counts of treated) / Live counts of control × 100
By labeling the target tumor cells with non-toxic, non-radioactive calcein AM or transfect with GFP, we can monitor the killing of the tumor cells by CAR-T cells. While live target cancer cells will be labeled by a green calcein AM or GFP, the dead cells cannot retain the green dye. Hoechst 33342 is used for stain all cells (both T cells and tumor cells), alternatively, target tumor cells can be stained with membrane bound calcein AM, PI is used for stain the dead cells (both T cells and tumor cells). This staining strategy allows for the discriminate of different cells.

 

 

 

E: T Ratio dependent Cytotoxicity of K562

 

The example Hoechst 33342, CFSE, PI fluorescent images are the K562 target cells at t = 3 hours
The resulting fluorescent images showed increase in Hoechst+CFSE+PI+ Target cells as E: T ratio increased

 

 

Download

File Download

  • This field is for validation purposes and should be left unchanged.

Request a demo

We appreciate your interest in our instruments. Please provide your information below and we will get back to you shortly.
  • This field is for validation purposes and should be left unchanged.

Request a Quote

We appreciate your interest in our instruments. Please provide your details below and we will get back to you shortly.
  • This field is for validation purposes and should be left unchanged.

Contact Us

Need help with your instrument? Contact our support team here.
  • This field is for validation purposes and should be left unchanged.

Your privacy is important for us.

We use cookies to enhance your experience when visiting our websites: performance cookies show us how you use this website, functional cookies remember your preferences and targeting cookies help us to share content relevant to you.

Accept

Login